Browsing Category
Healthcare Industry News
2469 posts
Conavi Medical (TSXV: CNVI) launches public offering to fund Novasight Hybrid U.S. rollout
Conavi Medical is raising capital via share and warrant offering to fund the U.S. launch of its next-gen Novasight Hybrid imaging system. Find out what’s next.
HMP Global acquires Music City SCALE in aesthetics education expansion
HMP Global acquires Music City SCALE to expand its aesthetics and dermatology education platform. Discover how this reshapes skin health learning in 2025.
Lumos Diagnostics (ASX: LDX) wins full U.S. Medicare reimbursement for FebriDx
Lumos Diagnostics secures full Medicare MAC reimbursement for FebriDx, opening doors to U.S. healthcare adoption. Find out what’s next for LDX shares.
Premier (NASDAQ: PINC) stockholders approve $2.6bn buyout by Patient Square Capital, closing set for November 25
Premier stockholders approve $2.6B sale to Patient Square Capital. Find out what this means for investors, healthcare tech, and future innovation.
What the Nasdaq determination letter means for Moolec Science’s future on the exchange
Moolec Science receives Nasdaq determination letter over sub-$1 share price. Find out what this means for its future and how it plans to respond.
Elanco (NYSE: ELAN) stock gains as FDA grants emergency use for Credelio CAT to combat New World screwworm in cats
Elanco stock jumps 4.76% as FDA approves Credelio CAT for emergency screwworm use. Find out what this means for feline health and investor momentum.
Why Veeva Systems (NYSE: VEEV) stock dropped after earnings despite strong Q3 FY2026 results
Find out how Veeva Systems beat Q3 expectations but still saw its stock drop — and what it means for growth, AI strategy, and investor sentiment.
GE HealthCare’s $2.3bn Intelerad acquisition boosts SaaS ambitions and lifts investor sentiment
GE HealthCare to acquire Intelerad for $2.3B to scale SaaS imaging across care settings. Explore what this means for investors and the AI roadmap.
PACS Group (NYSE: PACS) stock soars 149% in five days as restatement clears audit cloud and Q3 earnings beat forecasts
PACS Group stock surges 149 percent in five days after restatement and Q3 earnings beat. Find out what’s driving investor confidence and what to watch next.
Solventum (NYSE: SOLV) stock jumps 5% on $850m Acera Surgical acquisition deal
Solventum’s $850M Acera deal aims to reshape wound care strategy. See how synthetic matrices and Restrata could drive long-term growth.